SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-017597
Filing Date
2024-05-02
Accepted
2024-05-02 17:25:56
Documents
15
Period of Report
2024-04-29
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47304
2 ex16-1.htm EX-16.1 4695
  Complete submission text file 0001493152-24-017597.txt   274208

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE tvgn-20240429.xsd EX-101.SCH 3783
4 XBRL DEFINITION FILE tvgn-20240429_def.xml EX-101.DEF 26643
5 XBRL LABEL FILE tvgn-20240429_lab.xml EX-101.LAB 36743
6 XBRL PRESENTATION FILE tvgn-20240429_pre.xml EX-101.PRE 25267
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5876
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41002 | Film No.: 24909931
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)